Celon Pharma Project to Develop and Evaluate Dual JAK/ROCK Inhibitor
The project aims to develop and clinically evaluate a dual JAK/ROCK inhibitor for myasthenia gravis therapy.
The project aims to develop and clinically evaluate a dual JAK/ROCK inhibitor for myasthenia gravis therapy.